Conventional Magnetic Resonance Imaging for Brain Metastasis

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Brain Metastasis+1 MoreConventional Magnetic Resonance Imaging - Procedure
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing new MRI imaging techniques to see if they provide better images than standard MRI for patients with brain cancer.

Eligible Conditions
  • Brain Metastasis
  • Cancer

Treatment Effectiveness

Study Objectives

2 Primary · 1 Secondary · Reporting Duration: through study completion, an average of 1 year

Year 1
Conspicuity
Sensitivity
Treatment response

Trial Safety

Trial Design

1 Treatment Group

Diagnostic (advanced MRI)
1 of 1

Experimental Treatment

50 Total Participants · 1 Treatment Group

Primary Treatment: Conventional Magnetic Resonance Imaging · No Placebo Group · N/A

Diagnostic (advanced MRI)Experimental Group · 2 Interventions: Conventional Magnetic Resonance Imaging, Advanced Magnetic Resonance Imaging · Intervention Types: Procedure, Procedure

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, an average of 1 year

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
2,810 Previous Clinical Trials
1,790,521 Total Patients Enrolled
Jason M JohnsonPrincipal InvestigatorM.D. Anderson Cancer Center
6 Previous Clinical Trials
178 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
The MRI of the brain reveals at least one lesion that is greater than 5 mm in size which is most likely to be a metastasis.
A patient who has been diagnosed with cancer that has spread to one or more organs is considered to have a solid organ cancer.
therapy The patient will undergo a series of stereotactic radiation therapy treatments.